Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 13 matching records.
13 results — page 1 of 1
- Level BClinical TrialEurope PMC
Limitations of Stem Cell Therapy for Parkinson's Disease
Clinical Trial on Neuroinflammation, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level BClinical TrialEurope PMC
Stem cell therapy for Parkinson's disease: A new hope for neural regeneration
Clinical Trial on Neuroinflammation, published in World J Biol Chem (2025) — summary generated from the PubMed abstract.
- 2025
World J Biol Chem1 citations - Level CProspective StudyPubMed
Safety and efficacy of adipose-derived mesenchymal stem cell therapy in elderly Parkinson's disease patients: an intermediate-size expanded access program.
Prospective Study on Neuroinflammation, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy1 citations - Level DNarrative ReviewEurope PMC
Manipulated mesenchymal stem cell therapy in the treatment of Parkinson's disease
Narrative Review on Neuroinflammation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther3 citations - Level DNarrative ReviewEurope PMC
Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease
Narrative Review on Neuroinflammation, Immune Modulation, published in Curr Neuropharmacol (2023) — summary generated from the PubMed abstract.
- 2023
Curr Neuropharmacol12 citations - Level DAnimal StudyEurope PMC
VEGF-Expressing Mesenchymal Stem Cell Therapy for Safe and Effective Treatment of Pain in Parkinson's Disease
Animal Study on Neuroinflammation, published in Cell Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Cell Transplant14 citations - Level AMeta-analysisEurope PMC
Cell-therapy for Parkinson's disease: a systematic review and meta-analysis
Meta-analysis with a reported sample of 210 on Neuroinflammation, published in J Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 210
J Transl Med16 citations - Level DNarrative ReviewEurope PMC
Enriched Environment and Exercise Enhance Stem Cell Therapy for Stroke, Parkinson's Disease, and Huntington's Disease
Narrative Review on Stroke Research, Neuroinflammation, published in Front Cell Dev Biol (2022) — summary generated from the PubMed abstract.
- 2022
Front Cell Dev Biol28 citations - Level AMeta-analysisPubMed
Effectiveness and mechanisms of adipose-derived stem cell therapy in animal models of Parkinson's disease: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 169 on Neuroinflammation, published in Transl Neurodegener (2021) — summary generated from the PubMed abstract.
- 2021
- n = 169
Transl Neurodegener15 citations - Level BClinical TrialEurope PMC
Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease
Clinical Trial on Neuroinflammation, Immune Modulation, published in NPJ Regen Med (2020) — summary generated from the PubMed abstract.
- 2020
NPJ Regen Med56 citations - Level DNarrative ReviewPubMed
Mesenchymal stem cell therapy in Parkinson's disease animal models.
Narrative Review on Neuroinflammation, Immune Modulation, published in Curr Res Transl Med (2016) — summary generated from the PubMed abstract.
- 2016
Curr Res Transl Med34 citations - Level DAnimal StudyPubMed
Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy.
Animal Study on Neuroinflammation, published in Cytotherapy (2013) — summary generated from the PubMed abstract.
- 2013
Cytotherapy - Level CProspective StudyEurope PMC
Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy
Prospective Study on Neuroinflammation, published in Parkinsons Dis (2012) — summary generated from the PubMed abstract.
- 2012
Parkinsons Dis33 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406